Adam Laponis, Chief Financial Officer at Twist Bioscience Corp (TWST), sold 3,000 shares at $55.00 ($165K) on 2026-04-14, disclosed to the SEC on 2026-04-16.
Scheduled sale ($165k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TWST | SELL | 2026-08-25 | $273K | — | Filing → |
| TWST | SELL | 2026-07-13 | $226K | — | Filing → |
| TWST | SELL | 2026-06-02 | $280K | — | Filing → |